| 2020 |
| 04/01 | 10:00 エグゼクティブ報酬返還ポリシー(クローバックポリシー)の導入について |
| 03/26 | 3,260 | 3,288 | 3,187 | 3,233 | -3.35% | 10,816,700 | 5兆964億 | -9.74% |
| 03/25 | 3,205 | 3,353 | 3,181 | 3,345 | +10.4% | 11,341,700 | 5兆2729億 | -7.62% |
| 03/24 | 3,008 | 3,089 | 2,953 | 3,030 | +0.6% | 15,217,500 | 4兆7764億 | -17.15% |
| 03/23 | 3,019 | 3,054 | 2,982 | 3,012 | +3.19% | 13,578,200 | 4兆7479億 | -18.75% |
| 03/19 | 2,952 | 3,027 | 2,917 | 2,919 | +0.66% | 15,018,100 | 4兆6013億 | -22.37% |
| 03/18 | 3,016 | 3,023 | 2,900 | 2,900 | -4.29% | 18,114,900 | 4兆5714億 | -24.06% |
| 03/17 | 2,970 | 3,080 | 2,895 | 3,030 | -0.1% | 18,021,400 | 4兆7763億 | -21.87% |
| 03/16 | 3,101 | 3,136 | 3,003 | 3,033 | -2.32% | 10,984,100 | 4兆7810億 | -22.94% |
| 03/13 | 3,022 | 3,272 | 2,968 | 3,105 | -7.95% | 19,280,300 | 4兆8945億 | -22.24% |
| 03/12 | 3,580 | 3,592 | 3,373 | 3,373 | -8.32% | 14,825,400 | 5兆3170億 | -16.55% |
| 03/11 | 3,718 | 3,795 | 3,673 | 3,679 | -2.13% | 8,123,300 | 5兆7994億 | -9.74% |
| 03/10 | 3,640 | 3,794 | 3,555 | 3,759 | +2.15% | 9,057,900 | 5兆9255億 | -8.25% |
| 03/09 | 3,730 | 3,778 | 3,644 | 3,680 | -3.59% | 7,888,400 | 5兆8009億 | -10.57% |
| 03/06 | 3,830 | 3,867 | 3,816 | 3,817 | -2.03% | 7,478,600 | 6兆169億 | -7.76% |
| 03/05 | 3,904 | 3,924 | 3,857 | 3,896 | +3.51% | 9,232,200 | 6兆1414億 | -6.3% |
| 03/04 | 17:00 新型コロナウイルス感染症(COVID-19)治療薬としての血漿分画製剤開発の開始について |
| 03/04 | 3,763 | 3,809 | 3,749 | 3,764 | -0.95% | 5,402,900 | 5兆9334億 | -9.8% |
| 03/03 | 3,983 | 3,989 | 3,800 | 3,800 | +0.72% | 7,737,300 | 5兆9901億 | -9.39% |
| 03/02 | 3,738 | 3,840 | 3,730 | 3,773 | +0.27% | 7,636,800 | 5兆9475億 | -10.51% |
| 02/28 | 3,840 | 3,871 | 3,744 | 3,763 | -4.44% | 9,228,100 | 5兆9318億 | -11.25% |
| 02/27 | 4,012 | 4,021 | 3,901 | 3,938 | -2.43% | 7,277,000 | 6兆2076億 | -7.69% |
| 02/26 | 4,040 | 4,067 | 4,024 | 4,036 | -0.76% | 6,193,700 | 6兆3621億 | -5.81% |
| 02/25 | 4,023 | 4,123 | 4,023 | 4,067 | -3.83% | 7,735,300 | 6兆4110億 | -5.44% |
| 02/21 | 4,164 | 4,235 | 4,157 | 4,229 | +1.59% | 4,441,500 | 6兆6664億 | -2.02% |
| 02/20 | 4,205 | 4,228 | 4,163 | 4,163 | -1% | 3,762,300 | 6兆5623億 | -3.7% |
| 02/19 | 4,206 | 4,244 | 4,202 | 4,205 | -0.02% | 2,523,700 | 6兆6285億 | -2.93% |
| 02/18 | 4,220 | 4,241 | 4,193 | 4,206 | -0.85% | 2,861,100 | 6兆6301億 | -3.09% |
| 02/17 | 4,250 | 4,270 | 4,232 | 4,242 | -1.3% | 2,449,500 | 6兆6869億 | -2.42% |
| 02/14 | 4,287 | 4,300 | 4,248 | 4,298 | -0.65% | 4,101,000 | 6兆7751億 | -1.22% |
| 02/13 | 4,387 | 4,393 | 4,315 | 4,326 | -1.59% | 4,275,400 | 6兆8193億 | -0.53% |
| 02/12 | 4,410 | 4,412 | 4,376 | 4,396 | +0.73% | 4,459,100 | 6兆9296億 | +1.1% |
| 02/10 | 4,407 | 4,411 | 4,355 | 4,364 | -2.98% | 5,121,400 | 6兆8792億 | +0.48% |
| 02/07 | 4,481 | 4,526 | 4,471 | 4,498 | +1.08% | 5,117,900 | 7兆904億 | +3.59% |
| 02/06 | 4,432 | 4,462 | 4,393 | 4,450 | +2.82% | 6,859,100 | 7兆147億 | +2.63% |
| 02/05 | 4,368 | 4,415 | 4,294 | 4,328 | +2.37% | 6,474,200 | 6兆8224億 | -0.09% |
| 02/04 | 15:00 2020年3月期第3四半期決算短信〔IFRS〕(連結) |
| 02/04 | 15:00 通期連結業績(IFRS)の修正に関するお知らせ |
| 02/04 | 4,189 | 4,249 | 4,177 | 4,228 | +0.93% | 3,704,100 | 6兆6648億 | -2.4% |
| 02/03 | 4,175 | 4,211 | 4,132 | 4,189 | -0.9% | 4,585,800 | 6兆6033億 | -3.43% |
| 01/31 | 4,259 | 4,271 | 4,223 | 4,227 | -0.54% | 3,932,900 | 6兆6632億 | -2.74% |
| 01/30 | 4,271 | 4,273 | 4,213 | 4,250 | -1.48% | 3,943,800 | 6兆6995億 | -2.37% |
| 01/29 | 4,296 | 4,334 | 4,277 | 4,314 | +0.98% | 3,306,600 | 6兆8004億 | -1.1% |
| 01/28 | 4,262 | 4,296 | 4,250 | 4,272 | -0.58% | 4,327,000 | 6兆7341億 | -2.2% |
| 01/27 | 4,301 | 4,323 | 4,276 | 4,297 | -1.15% | 3,289,500 | 6兆7736億 | -1.81% |
| 01/24 | 4,380 | 4,398 | 4,340 | 4,347 | -0.39% | 3,885,100 | 6兆8524億 | -0.8% |
| 01/23 | 4,395 | 4,396 | 4,363 | 4,364 | -0.98% | 2,677,000 | 6兆8792億 | -0.48% |
| 01/22 | 17:00 連結子会社(持株会社)の清算に関するお知らせ |
| 01/22 | 4,403 | 4,425 | 4,396 | 4,407 | -0.32% | 2,776,900 | 6兆9470億 | +0.46% |
| 01/21 | 4,434 | 4,454 | 4,399 | 4,421 | -0.36% | 2,221,400 | 6兆9690億 | +0.82% |
| 01/20 | 4,417 | 4,467 | 4,414 | 4,437 | +0.09% | 2,351,300 | 6兆9942億 | +1.19% |
| 01/17 | 4,406 | 4,438 | 4,388 | 4,433 | +0.61% | 2,716,800 | 6兆9879億 | +1.14% |
| 01/16 | 4,443 | 4,456 | 4,399 | 4,406 | +0.16% | 3,089,200 | 6兆9454億 | +0.57% |
| 01/15 | 4,419 | 4,419 | 4,382 | 4,399 | -0.2% | 2,701,700 | 6兆9343億 | +0.39% |
| 01/14 | 20:00 事業変革の進捗と優先事項の概要について第38回J.P.モルガン・ヘルスケア・カンファレンスにて発表 |
| 01/14 | 4,435 | 4,435 | 4,380 | 4,408 | +0.66% | 3,567,800 | 6兆9485億 | +0.55% |
| 01/10 | 4,348 | 4,379 | 4,340 | 4,379 | +0.85% | 2,663,500 | 6兆9028億 | -0.16% |
| 01/09 | 4,318 | 4,359 | 4,310 | 4,342 | +2.16% | 4,011,300 | 6兆8445億 | -1.09% |
| 01/08 | 4,273 | 4,297 | 4,217 | 4,250 | -0.91% | 5,522,900 | 6兆6995億 | -3.3% |
| 01/07 | 4,280 | 4,303 | 4,241 | 4,289 | +0.4% | 3,751,900 | 6兆7609億 | -2.61% |
| 01/06 | 4,297 | 4,305 | 4,232 | 4,272 | -1.39% | 4,720,600 | 6兆7341億 | -3.17% |
| 2019 |
| 12/30 | 4,335 | 4,355 | 4,319 | 4,332 | -0.73% | 2,537,200 | 6兆8287億 | -2.01% |
| 12/27 | 4,343 | 4,389 | 4,334 | 4,364 | +0.6% | 2,268,500 | 6兆8792億 | -1.36% |
| 12/26 | 4,344 | 4,344 | 4,325 | 4,338 | -0.21% | 2,148,900 | 6兆8382億 | -2.01% |
| 12/25 | 4,365 | 4,377 | 4,342 | 4,347 | -0.44% | 1,499,900 | 6兆8524億 | -1.94% |
| 12/24 | 4,366 | 4,427 | 4,354 | 4,366 | -0.41% | 2,422,500 | 6兆8823億 | -1.67% |
| 12/23 | 4,380 | 4,402 | 4,334 | 4,384 | -0.48% | 3,347,400 | 6兆9107億 | -1.44% |
| 12/20 | 4,461 | 4,467 | 4,373 | 4,405 | -1.54% | 5,685,900 | 6兆9438億 | -1.08% |
| 12/19 | 4,472 | 4,492 | 4,453 | 4,474 | +0.09% | 3,131,200 | 7兆526億 | +0.43% |
| 12/18 | 4,480 | 4,480 | 4,448 | 4,470 | +0.04% | 2,943,200 | 7兆463億 | +0.43% |
| 12/17 | 4,447 | 4,468 | 4,427 | 4,468 | +0.68% | 3,461,600 | 7兆431億 | +0.47% |
| 12/16 | 17:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの締め切りと結果に関するお知らせ |
| 12/16 | 4,426 | 4,449 | 4,411 | 4,438 | +0.27% | 2,524,300 | 6兆9958億 | -0.05% |
| 12/13 | 4,464 | 4,480 | 4,423 | 4,426 | +0.39% | 5,372,600 | 6兆9769億 | -0.2% |
| 12/12 | 4,365 | 4,425 | 4,347 | 4,409 | +0.87% | 3,614,700 | 6兆9501億 | -0.54% |
| 12/11 | 4,417 | 4,417 | 4,352 | 4,371 | -1.15% | 3,218,800 | 6兆8902億 | -1.29% |
| 12/10 | 4,399 | 4,422 | 4,379 | 4,422 | +1.17% | 3,508,400 | 6兆9706億 | 0% |
| 12/09 | 4,400 | 4,400 | 4,361 | 4,371 | -0.32% | 3,207,600 | 6兆8902億 | -0.97% |
| 12/06 | 4,440 | 4,441 | 4,376 | 4,385 | -1.44% | 3,897,600 | 6兆9123億 | -0.32% |
| 12/05 | 4,466 | 4,486 | 4,442 | 4,449 | +0.43% | 3,374,500 | 7兆132億 | +1.55% |
| 12/04 | 4,415 | 4,450 | 4,408 | 4,430 | -0.85% | 4,003,900 | 6兆9832億 | +1.65% |
| 12/03 | 4,436 | 4,519 | 4,432 | 4,468 | -0.51% | 4,020,200 | 7兆431億 | +3.04% |
| 12/02 | 4,485 | 4,510 | 4,473 | 4,491 | +0.81% | 3,471,800 | 7兆794億 | +4.2% |
| 11/29 | 17:00 第143期(中間期)事業活動のご報告 |
| 11/29 | 4,499 | 4,500 | 4,447 | 4,455 | -0.65% | 3,135,800 | 7兆226億 | +3.99% |
| 11/28 | 4,492 | 4,509 | 4,467 | 4,484 | -0.18% | 2,797,400 | 7兆683億 | +5.28% |
| 11/27 | 4,510 | 4,517 | 4,488 | 4,492 | +0.38% | 3,208,000 | 7兆809億 | +6.14% |
| 11/26 | 4,438 | 4,512 | 4,437 | 4,475 | +1.27% | 7,312,000 | 7兆541億 | +6.45% |
| 11/25 | 4,481 | 4,509 | 4,416 | 4,419 | -0.67% | 3,895,300 | 6兆9659億 | +5.79% |
| 11/22 | 4,409 | 4,461 | 4,366 | 4,449 | -0.4% | 4,895,900 | 7兆132億 | +7.13% |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(6⁄6) |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(5⁄6) |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(4⁄6) |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(3⁄6) |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(2⁄6) |
| 11/21 | 10:40 R&DおよびPDT説明会(2019年11月21日東京開催)プレゼンテーション資料(1⁄6) |
| 11/21 | 4,495 | 4,500 | 4,397 | 4,467 | -1.37% | 6,768,700 | 7兆415億 | +8.19% |
| 11/20 | 4,530 | 4,543 | 4,512 | 4,529 | -0.72% | 4,303,000 | 7兆1393億 | +10.44% |
| 11/19 | 4,490 | 4,562 | 4,487 | 4,562 | +1.18% | 7,828,200 | 7兆1913億 | +12.12% |
| 11/18 | 4,480 | 4,532 | 4,470 | 4,509 | +1.19% | 8,366,000 | 7兆1077億 | +11.77% |
| 11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(4⁄4) |
| 11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(3⁄4) |
| 11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(2⁄4) |
| 11/15 | 20:00 PDT説明会(2019年11月15日コビントン開催)プレゼンテーション資料(1⁄4) |
| 11/15 | 4,434 | 4,481 | 4,407 | 4,456 | +1.92% | 6,700,900 | 7兆242億 | +11.34% |
| 11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(4⁄5) |
| 11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(3⁄5) |
| 11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(2⁄5) |
| 11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(1⁄5) |
| 11/14 | 20:00 R&D説明会(2019年11月14日NY開催)プレゼンテーション資料(5⁄5) |
| 11/14 | 18:00 2021年満期米ドル建普通社債、2023年満期米ドル建普通社債及び2028年満期米ドル建普通社債のエクスチェンジ・オファーの開始に関するお知らせ |
| 11/14 | 4,399 | 4,438 | 4,358 | 4,372 | +0.05% | 5,840,500 | 6兆8918億 | +10.1% |
| 11/13 | 4,307 | 4,382 | 4,275 | 4,370 | +1.56% | 5,678,400 | 6兆8886億 | +10.89% |
| 11/12 | 4,300 | 4,332 | 4,263 | 4,303 | -0.37% | 3,946,200 | 6兆7830億 | +9.99% |
| 11/11 | 4,400 | 4,406 | 4,304 | 4,319 | -1.35% | 5,328,300 | 6兆8082億 | +11.11% |
| 11/08 | 4,320 | 4,390 | 4,309 | 4,378 | +2.34% | 9,588,600 | 6兆9012億 | +13.27% |
| 11/07 | 4,266 | 4,299 | 4,231 | 4,278 | +1.21% | 6,494,500 | 6兆7436億 | +11.41% |
| 11/06 | 4,197 | 4,227 | 4,152 | 4,227 | +0.55% | 6,623,300 | 6兆6632億 | +10.74% |
| 11/05 | 4,070 | 4,213 | 4,061 | 4,204 | +5.1% | 10,314,400 | 6兆6270億 | +10.66% |
| 11/01 | 3,949 | 4,023 | 3,919 | 4,000 | +1.83% | 7,995,500 | 6兆3054億 | +5.65% |
| 10/31 | 15:00 通期連結業績(IFRS)の修正に関するお知らせ |
| 10/31 | 15:00 2020年3月期第2四半期決算短信[IFRS](連結) |
| 10/31 | 3,940 | 3,950 | 3,909 | 3,928 | +1.05% | 4,576,200 | 6兆1919億 | +3.92% |
| 10/30 | 3,890 | 3,933 | 3,872 | 3,887 | +0.26% | 8,450,500 | 6兆1272億 | +2.99% |
| 10/29 | 3,855 | 3,881 | 3,851 | 3,877 | +1.39% | 4,178,500 | 6兆1115億 | +2.84% |
| 10/28 | 3,843 | 3,843 | 3,812 | 3,824 | -0.31% | 2,474,100 | 6兆279億 | +1.57% |
